AMASS Brands (AMSS) Q2 2026 earnings review

A Disastrous Public Debut Disguised by Core Brand Growth

Management's press release highlights the 'defining milestone' of a Nasdaq direct listing and 12% growth in core brands. The 10-Q tells a much darker story. Despite a modest 2% YoY revenue increase, gross margins collapsed by 1,230 bps to 26.7% as the company resorted to deep discounts to clear inventory. The costs of going public caused G&A to explode by 216%, driving a massive $7.5M net loss for the quarter. Most alarmingly, operating cash burn hit $6.1M for the half-year against just $1.6M in cash, and AMASS received a Nasdaq delisting warning a mere two months after its debut. The ambitious FY27 guidance assumes a survival that current liquidity barely supports.

🐂 Bull Case

Non-Alcoholic Portfolio is Scaling Fast

The Non-Alcoholic and Functional segment revenue more than doubled (+132% YoY) to $0.4M, driven by Good Twin taking the #1 U.S. organic non-alcoholic wine spot and the successful launch of AMASS Electrolytes.

Portfolio Pruning Underway

Core brands now represent 67% of brand revenue (up from 62%), while discontinued brands are being aggressively wound down (-27% YoY). The company is successfully shedding dead weight.

🐻 Bear Case

Severe Liquidity & Going Concern Risk

The company holds just $1.6M in cash against $17.6M in near-term material cash requirements. The 10-Q explicitly states 'substantial doubt' about their ability to continue as a going concern.

Nasdaq Delisting Notice

Just two months post-listing, AMASS received delisting notices for falling below the $50M market value threshold, triggering a penalty clause on their Series C preferred stock that will further dilute equity.

⚖️ Verdict: 🔴🔴

Very Bearish. The pivot to functional beverages is working, but it represents less than 10% of revenue. The core business is bleeding cash, margins are collapsing from inventory clearance, and the immediate threat of delisting and insolvency overshadows any product-level victories.

Key Themes

CONCERN NEW 🔴🔴

The Public Listing Facade Cracks Immediately

In the press release, the CEO called the May Nasdaq direct listing a 'defining milestone'. What wasn't mentioned in the PR: on July 22, the company received two Nasdaq delisting notices for falling below minimum market value requirements. This is a massive red flag. The notice constitutes a 'Trigger Event' on their Series C Convertible Preferred Stock, allowing the investor (Streeterville) to convert shares at a severely discounted floating price, heavily diluting existing shareholders and potentially cutting off future funding access.

CONCERN 🔴

Margin Collapse Driven by Fire Sales

Reversing trend. Gross profit fell 30% YoY despite higher revenue. Gross margin plummeted from 39.0% to 26.7%. Management admits they are accepting 'near-term margin pressure to simplify the portfolio and convert inventory into cash.' Specifically, they dumped Calirosa Añejo to a discount grocery retailer at a gross loss and took $0.1M in inventory write-downs. Selling inventory below cost to generate emergency cash is a symptom of severe distress.

DRIVER NEW 🟢

Non-Alcoholic Segment is the Lone Bright Spot

Accelerating. The Non-Alcoholic and Functional segment is working. Revenue surged 132% YoY to $0.41M. Good Twin captured over one-third of the U.S. organic non-alcoholic wine category dollars, and the newly launched AMASS Electrolytes generated its first commercial revenue. While currently a small piece of the pie (7% of total sales), it is the company's only viable growth engine.

CONCERN 🔴

Macro Headwinds: Tariffs and Freight Choking Margins

Beyond the self-inflicted inventory discounts, macro realities are biting. The company explicitly cited tariffs on imported wine increasing landed product costs, alongside elevated freight rates. The Non-Alcoholic segment's margins were specifically hit by using 'expedited modes of freight' to keep Good Twin in stock during rapid growth.

DRIVER 🟢

Core Brand Optimization

Management is forcefully shifting the mix. Core brands (Summer Water, Pizzolato, Good Twin, Electrolytes) grew 12% and now make up 67% of brand revenue, up from 62% last year. Meanwhile, brands they are actively discontinuing plummeted 27%. This intentional shrinkage of the unprofitable tail is the right long-term move, provided they can survive the short-term cash crunch.

DRIVER NEW 🟢

Functional Hydration Expansion via HpO

AMASS announced the planned acquisition of a majority stake in HpO (a zero-sugar sparkling protein water brand). They formalized a $0.3M SAFE investment in June. This pushes the company further into the multi-billion-dollar functional wellness category, intersecting protein consumption with premium hydration.

Other KPIs

Operating Cash Flow vs Cash Balance -$6.1 million burn vs $1.6 million cash

Accelerating burn. Operating cash outflow worsened from -$1.3M in H1 2025 to -$6.1M in H1 2026. The company is surviving entirely on the $7.0M raised from the Series C Preferred Stock, but with only $1.6M left and $16.8M in short-term cash obligations (including $3.8M on their credit facility and $6.1M in supplier payables), they are in immediate danger of a liquidity crisis.

Wine & Spirits Segment Revenue $5.18 million

Decelerating. Revenue fell 3% YoY from $5.32M in the prior year. The decline reflects the intentional winding down of legacy spirits products and discontinued wine labels. While necessary for long-term health, this segment still makes up 93% of total revenue, meaning the total company top-line will remain stagnant until the Non-Alcoholic segment gets substantially larger.

Guidance

Q3 2026 Revenue At least $4.4 million

Accelerating. Represents at least 10% YoY growth. This would be a meaningful step up from the 2% YoY growth seen in Q2, driven by assumed stabilization in the Wine & Spirits segment and continued hyper-growth in Non-Alcoholics.

FY26 Revenue At least $18.5 million

Accelerating. Implies at least 4% YoY growth. With H1 coming in at $9.74M, this implies H2 revenue of $8.76M (roughly 10% YoY growth for the half). Management states this is intentionally set at 'achievable' levels.

FY27 Revenue At least $22.2 million

Accelerating. Implies at least 20% growth over FY26. While the pipeline of new products (Electrolytes, HpO) supports a growth narrative, achieving this is highly contingent on securing the necessary working capital to survive 2026.

Key Questions

Nasdaq Deficiency Cure

You received notice of failure to meet Nasdaq's $50M market value requirement in July. Given the resulting 'Trigger Event' on your Series C stock, what is the concrete plan to regain compliance by January 2027 without triggering a catastrophic dilution spiral?

Cash Runway Reality

With $1.6M in cash and a six-month operating burn of $6.1M, how many months of runway remain before the Streeterville facility is completely exhausted, and how are you managing supplier payables which currently sit at over $6M?

Margin Floor

Gross margins hit 26.7% due to inventory clearance and tariffs. When do you expect the inventory dumping to be fully completed, and what is the baseline gross margin we should expect going into Q4?